Call customer care on: 0333 358 0200
Dr Ruch Karunadasa

Authored on 24 January 2024 by Dr Ruch Karunadasa,

Reviewed 24 January 2024 by Dr Adeel Arshad.

Dovobet Ointment

Cream medication

A combination ointment, containing betamethasone and calcipotriol, used in the treatment of stable plaque psoriasis vulgaris in adults.

Medication effect duration

Like any other prescription medication you must consult a doctor before using it. PrivateDoc offers a confidential free consultation service that may result in you receiving a prescription for Dovobet Ointment if it is deemed appropriate and Dovobet Ointment can prescribed safely.

Skin treatment

Complete a 100% free and secure consultation to explore your treatment options. How our online prescription consultation works.


Each 1 gram of ointment includes –

Calcipotriol monohydrate 50micrograms

Betamethasone dipropionate 0.5mg

A full list of non-active ingredients (excipients) can be found by clicking here to access the patient information leaflet.

How much does Dovobet Ointment cost?

What conditions can Dovobet Ointment be used for

Dovobet Ointment is used in the treatment of stable plaque psoriasis vulgaris in adults that are likely to or have in the past responded to topical therapy.

Get Started

How to use Dovobet Ointment

Dovobet Ointment should be used exactly as your prescriber has instructed. The calcipotriol helps to reduce the rate at which your skin cells reproduce, and the betamethasone reduces the redness/inflammation.

The usual recommend dose is applying the ointment once daily to the affected area(s) only. Treatment length is usually 4 weeks, but repeated courses can be given for up to 52 weeks under medical supervision.

Topical preparations which include calcipotriol should not exceed a maximum daily dose of 15g. Dovobet Ointment should not be used on more than 30% of the body surface area.

Full instructions can be found in the product literature by clicking here.

Who cannot use Dovobet Ointment

Dovobet Ointment should not be used by anyone who has had a hypersensitivity reaction to either the active ingredients or any of the excipients. It is licensed for psoriasis vulgaris only and should not be used to treat erythrodermic, exfoliative or pustular psoriasis.

Dovobet Ointment should be avoided in any patient with a known calcium metabolism disorder. The corticosteroid content means it should be avoided in patients that have a rash caused by a virus (chickenpox, shingles, cold sores, etc.). Dovobet should also be avoided in patients where there is a likelihood of a fungal/bacterial infection or where the skin is broken.

A full list of contraindications and cautions is available by clicking here to access the full summary of product characteristics.

Get Started

Pregnancy and breastfeeding

There is no adequate data for use during pregnancy. Studies in animals with glucocorticoids have shown a level of toxicity but the impact of this in humans is uncertain. Therefore, Dovobet should only be used in pregnant females is the benefits of therapy outweigh the potential risks to the unborn foetus.

Betamethasone can pass into the breast milk but at therapeutic doses is not known to be harmful. There is no data on the excretion of calcipotriol in breast milk. Dovobet Ointment should be prescribed with caution to breastfeeding mothers. The ointment should not be used on the breasts if the mother is breastfeeding.

Side effects

Dovobet Ointment is generally well tolerated, but as is the case with all medication, a minority of patients may experience side effects from using the drug.

Side effects can include –

  • Hypersensitivity reactions
  • Blurred vision
  • Skin irritation
  • Skin atrophy
  • Hypercalcaemia
  • Rebound effects

A more complete list of side effects can be found in the patient information leaflet.

Get Started

Useful links

Click here for the Dovobet Ointment patient information leaflet

Click here for the Dovobet Ointment summary of product characteristics

Click here for the NHS psoriasis web link.

Ready for your online visit?